Skip to main content

Volume 15 Supplement 1

B cells in autoimmune diseases: Part 2

B cells in autoimmune diseases

Reviews

The supplement was proposed by the journal and content was developed in consultation with the Editors-in-Chief. Articles have been independently prepared by the authors and have undergone the journal's standard peer review process. Publication of the supplement was supported by Medimmune.

This supplement is being published in two parts. Part 1 can be found at http://arthritis-research.com/supplements/14/S5. Further articles will be added to this supplement later in the year.

  1. B cell abnormalities contribute to the development and progress of autoimmune disease.Traditionally, the role of B cells in autoimmune disease was thought to be predominantly limited tothe production of autoan...

    Authors: Ioannis Kalampokis, Ayumi Yoshizaki and Thomas F Tedder
    Citation: Arthritis Research & Therapy 2013 15(Suppl 1):S1
    Content type: Review Published on:

  2. B cells are believed to be central to the disease process in systemic lupuserythematosus (SLE), making them a target for new therapeutic intervention. In recentyears there have been many publications regarding...

    Authors: Venkat Reddy, David Jayne, David Close and David Isenberg
    Citation: Arthritis Research & Therapy 2013 15(Suppl 1):S2
    Content type: Review Published on:

  4. B lymphocytes are the source of humoral immunity and are thus a critical component of the adaptive immune system. However, B cells can also be pathogenic and the origin of disease. Deregulated B-cell function ...

    Authors: Stephan Blüml, Kathleen McKeever, Rachel Ettinger, Josef Smolen and Ronald Herbst
    Citation: Arthritis Research & Therapy 2013 15(Suppl 1):S4
    Content type: Review Published on:
  • Logo
Submit manuscript

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.4
    5-year Journal Impact Factor: 4.9
    Source Normalized Impact per Paper (SNIP): 1.294
    SCImago Journal Rank (SJR): 1.518

    Speed 2023
    Submission to first editorial decision (median days): 9
    Submission to acceptance (median days): 111

    Usage 2023
    Downloads: 3,331,819
    Altmetric mentions: 1,885

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us